India needs regulatory data protection to attract drug research: Novartis CEO

If one looks at any place in the world where there is significant fundamental drug research happening from multinational firms, there is regulatory data protection, including China, Narasimhan further said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/W5chL3l
via IFTTT